Clinical Trials Logo

Arthralgia clinical trials

View clinical trials related to Arthralgia.

Filter by:

NCT ID: NCT00857012 Completed - Breast Cancer Clinical Trials

Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)

COMPACT
Start date: April 2009
Phase: N/A
Study type: Observational

Patients are eligible for inclusion in this NIS if they have taken anastrozole either upfront or following two to three years of tamoxifen treatment ("switch") for at least three and not more than six months prior to offering an individual participation in this program. Treatment should follow local therapy guidelines and standard practice. Treatment decisions for patients participating in this study including assessments or supportive therapy during follow-up visits will also follow guidelines and remain independent of the program.

NCT ID: NCT00826397 Completed - Breast Cancer Clinical Trials

Acupuncture for Aromatase Inhibitor Induced Joint Pain

Start date: June 2005
Phase: N/A
Study type: Interventional

This is a randomized, controlled, pilot study to determine the safety and efficacy of acupuncture as an adjunct to pharmacological treatment compared to pharmacological intervention alone for the treatment of musculoskeletal pain related to aromatase inhibitors (AI) in postmenopausal breast cancer patients. Twenty participants (20 in each arm) will be enrolled at the Breast Oncology clinic at Columbia University Medical Center (CUMC). Patients in the treatment arm will receive acupuncture administered twice weekly for six weeks and will be allowed to take pain medication as necessary. The control patients will initially receive pain medication alone, then will cross-over to the acupuncture arm after six weeks. The investigators hypothesize that acupuncture will reduce AI induced joint symptoms. The study will enroll a total of 40 patients, half of whom will be randomized to one of the two arms to receive acupuncture plus pharmacological treatment (arm A) or pharmacological treatment alone (arm B). Joint pain will be assessed by the BPI-SF score at baseline and six weeks. All patients will have a baseline BPI worst pain item (#2) ≥3 points on a scale of 0-10.

NCT ID: NCT00738998 Terminated - Breast Cancer Clinical Trials

Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors

Start date: June 5, 2008
Phase: N/A
Study type: Interventional

The goal of this research study is to learn more about what it is like for patients with breast cancer to receive treatment with the drug anastrozole. Researchers want to learn about possible symptoms, such as joint pain, that patients may experience during treatment. Researchers also want to learn more about which patients are most likely to have joint symptoms by looking at certain proteins from routine blood draw samples.

NCT ID: NCT00702858 Completed - Breast Cancer Clinical Trials

Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

Start date: April 2008
Phase: N/A
Study type: Interventional

This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT). Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.

NCT ID: NCT00691678 Completed - Breast Cancer Clinical Trials

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

Start date: October 2008
Phase: Phase 2
Study type: Interventional

Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors.

NCT ID: NCT00660244 Completed - Arthralgia Clinical Trials

Breast Cancer Tumor Care Observational Programme

Start date: February 2008
Phase: N/A
Study type: Observational

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

NCT ID: NCT00613938 Completed - Pain Clinical Trials

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.

Start date: February 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of tapentadol (CG5503) compared with oxycodone and with placebo in subjects who have had a bunionectomy.

NCT ID: NCT00537589 Completed - Arthritis Clinical Trials

Ultrasound Guided Arthrocentesis

UGA
Start date: December 2004
Phase: N/A
Study type: Interventional

Does ultrasound guidance improve success rate and decrease aspiration attempts for peripheral arthrocentesis?

NCT ID: NCT00510536 Completed - Arthritis Clinical Trials

Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

Start date: July 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate tolerability and effectiveness of conventional treatment for mild to moderate arthritic or arthralgic symptoms while subjects are being treated with efalizumab for psoriasis.

NCT ID: NCT00497458 Unknown status - Breast Cancer Clinical Trials

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

ART2
Start date: July 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether increasing blood levels of androgen can reduce some of the side-effects of anti-estrogen therapy (Arimidex)